The Pharmaceutical Market: Jordan

Date: January 31, 2013
Pages: 112
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PAC68F7342BEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Jordan
OVERVIEW OF THE PHARMACEUTICAL MARKET IN JORDAN

We expect that Jordan will continue to provide modest opportunities to research-based pharmaceutical manufacturers. In line with the authorities' efforts to expand healthcare insurance coverage , we envisage measures aiming to promote the use of cheaper generic medicines, in tandem with price-reduction strategies. Nevertheless, the expansion of government provision and the higher uptake of generic medicines will conspire to keep longer term growth steady , boosted by upward volume changes, with the patented drug market to continue to be supported by rising numbers of medical tourists.

Headline Expenditure Projections

Pharmaceuticals: JOD463mn (US$653mn) in 2011 to JOD501mn (US$707mn) in 2012; +8.1% in local currency terms and +8.1% in US dollar terms. Forecast unchanged from Q 4 12 .

Healthcare: JOD1.73bn (US$2.45bn) in 2011 to JOD1.87bn (US$2.65bn) in 2012; +8.0% in local currency terms and +8.1% in US dollar terms. Forecast unchanged from Q 4 12 .

Medical devices: JOD112mn (US$158mn) in 2011 to JOD121mn (US$171mn) in 2012; +8.3% in local currency terms and +8.4% in US dollar terms. Forecast unchanged from Q 4 12 .

Risk/Reward Rating: Jordan's composite Pharmaceutical Risk/Reward Ratings score for Q113 remains unchanged in relation to the previous quarter. At 49.9 out of the maximum 100, Jordan is again ranked 10th, out of the 30 markets surveyed in the Middle East and Africa region. Jordan's rewards and risk scores remain evenly balanced, with both components standing firmly above the regional averages.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Jordan Pharmaceuticals And Healthcare Industry SWOT
    Jordan Political SWOT
    Jordan Economic SWOT
    Jordan Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

JORDAN – MARKET SUMMARY

REGULATORY REGIME

    Regulatory Developments
    Intellectual Property Regime
    IP Concerns
    Counterfeit Pharmaceuticals
    Pricing And Reimbursement Regime
    Pricing And Reimbursement Developments
    Public Sector Procurement Of Medicines
    International Collaboration

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Table: Primary Health Centre Visits by Condition, 2004-2010
    Non-Communicable Diseases
    Table: Diabetes Care Costs In 10 Middle Eastern Countries With Highest Prevalence
    Communicable Diseases
    Table: HIV/AIDS Patients, 1986-2010
    Table: Notifiable Communicable Diseases & Conditions, 2002-2010
    Healthcare Sector
    Healthcare Provision
    Table: MoH Health Centres, 2004-2010
    Table: Physicians by Sector, 2005-2010
    Secondary Care
    Table: Hospitals by Sector, 2001-2010
    Recent Healthcare Sector Developments
    Healthcare Funding
    Table: MoH Budget, 1995-2010 (JOD ‘000s)
    Healthcare Insurance
    Medical Tourism
    Research And Development Sector
    Biotechnology
    Clinical Trials
    Medical Devices

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Pharmaceutical Sales, 2008-2016
      Healthcare Market Forecast
      Table: Overall Healthcare Expenditure, 2008-2016
      Table: Government Healthcare Expenditure, 2008-2016
      Table: Private Healthcare Expenditure, 2008-2016
      Key Growth Factors – Macroeconomic
      Table: Jordan - Economic Activity
      Prescription Drug Market Forecast
      Table: Prescription Drug Sales, 2008-2016
      Patented Drug Market Forecast
      Table: Patented Drug Sales, 2008-2016
      Generic Drug Market Forecast
      Table: Generic Drug Sales, 2008-2016
      OTC Medicine Market Forecast
      Table: OTC Medicine Sales, 2008-2016
      Pharmaceutical Trade Forecast
      Table: Pharmaceutical Trade, 2008-2016
      Medical Device Market Forecast
      Table: Medical Device Sales, 2008-2016
      Other Healthcare Data Forecasts
      Key Risks To BMI’s Forecasts

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry
      Domestic Pharmaceuticals Sector
      Foreign Companies
      Pharmaceutical Wholesale Sector
      Retail Pharmacy Sector
      Table: Pharmacists by Sector, 2010

COMPANY PROFILES

  Local Companies
      Pharma International Company
      Arab Pharmaceutical Manufacturing Company (Hikma)
      Dar al-Dawa
      Hikma Pharmaceuticals
      Jordanian Pharmaceutical Manufacturing Company (JPM)
      United Pharmaceutical Manufacturers
  Multinational Companies
      Pfizer
      GlaxoSmithKline
      Novartis
      Sanofi
      Merck & Co

DEMOGRAPHIC DATA

      Table: Population By Age Group, 1990-2020 (‘000)
      Table: Population By Age Group, 1990-2020 (% of total)
      Table: Key Population Ratios, 1990-2020
      Table: Rural/Urban Population Split, 1990-2020

GLOSSARY

BMI METHODOLOGY

      How We Generate Our Pharmaceutical Industry Forecasts

PHARMACEUTICAL RISK/REWARD RATINGS METHODOLOGY

RATINGS OVERVIEW

TABLE: PHARMACEUTICAL RISK/REWARD INDICATORS

WEIGHTING

TABLE: WEIGHTING OF COMPONENTS

SOURCES
Skip to top


The Pharmaceutical Market: Indonesia US$ 1,295.00 Jan, 2013 · 117 pages
The Pharmaceutical Market: Italy US$ 1,295.00 Jan, 2013 · 76 pages
The Pharmaceutical Market: Japan US$ 1,295.00 Jan, 2013 · 99 pages

Ask Your Question

The Pharmaceutical Market: Jordan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: